Statera Biopharma, Inc.
Statera Biopharma, Inc. (STAB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 4 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Sep 28, 2021 involved a transaction of 100,000 shares valued at $0.
STAB Insider Activity Summary
Who Is Buying STAB Stock?
No significant insider buying has been recorded for STAB in the recent period.
Who Is Selling STAB Stock?
No significant insider selling has been recorded for STAB in the recent period.
Is Statera Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for STAB is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
STAB Frequently Asked Questions
Understanding STAB Insider Activity
Insider trading at Statera Biopharma, Inc. (STAB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading STAB stock, having executed 4 transactions in the past 90 days. The most active insider is Taunia Markvicka (Executive), who has made 1 transactions totaling $0.
Related Tools
Track Statera Biopharma, Inc. Insider Activity
Get notified when executives and directors at STAB file new Form 4 transactions